Optimizing Donor Cellular Dissociation and Subretinal Injection Parameters for Stem Cell‐Based Treatments

Subretinal delivery of stem cell‐derived retinal cells as a strategy to treat retinal degenerative blindness holds great promise. Currently, two clinical trials are underway in which human fetal retinal progenitor cells (RPCs) are being delivered to patients by intravitreal or subretinal injection t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Stem Cells Transl Med
Päätekijät: Scruggs, Brittni A., Jiao, Chunhua, Cranston, Cathryn M., Kaalberg, Emily, Wang, Kai, Russell, Stephen R., Wiley, Luke A., Mullins, Robert F., Stone, Edwin M., Tucker, Budd A., Sohn, Elliott H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2019
Aiheet:
Standards, Protocols, Policies, and Regulations for Cell‐Based Therapies
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6646699/
https://ncbi.nlm.nih.gov/pubmed/31004408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.18-0210
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia